NASDAQ:SILK
Silk Road Medical, Inc
- Stock
Last Close
19.23
09/05 18:49
Market Cap
590.02M
Beta: 1.17
Volume Today
326.06K
Avg: 562.88K
PE Ratio
−10.96
PFCF: −20.84
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -19.36M - | -37.63M 94.41% | -52.41M 39.29% | -47.37M 9.63% | -49.81M 5.16% | -55.01M 10.44% | -55.74M 1.33% | |
depreciation and amortization | 129K - | 517K 300.78% | 1.29M 150.29% | 1.39M 7.50% | 1.92M 37.96% | 3.17M 65.09% | 3.79M 19.70% | |
deferred income tax | -2.47M - | 13.92M 663.23% | 21.17M 52.06% | -2.25M 110.64% | 669K 129.69% | -59.80M - | ||
stock based compensation | 535K - | 911K 70.28% | 2.98M 226.78% | 7.23M 142.73% | 14.61M 102.21% | 25.02M 71.25% | 38.89M 55.43% | |
change in working capital | -5.88M - | -1.04M 82.34% | -3.05M 193.17% | -1.37M 54.89% | -6.48M 371.76% | -6.03M 7.03% | -13.91M 130.88% | |
accounts receivables | -4.79M - | -1.00M 79.07% | -2.24M 123.43% | -437K 80.50% | -2.77M 533.64% | -6.17M 122.90% | -5.61M 9.11% | |
inventory | -2.41M - | -2.56M 6.52% | -4.70M 83.08% | -2.16M 53.98% | -5.56M 157.43% | -1.45M 73.99% | -10.78M 645.06% | |
accounts payables | 678K - | -309K 145.58% | 615K 299.03% | 592K 3.74% | -1.16M 295.78% | 967K 183.43% | 3.06M 216.75% | |
other working capital | 641K - | 2.84M 342.75% | 3.28M 15.43% | 632K 80.71% | 3.01M 376.11% | 626K 79.20% | -585K 193.45% | |
other non cash items | 1.79M - | 1.62M 9.53% | 409K 74.80% | 307K 24.94% | 158K 48.53% | 264K 67.09% | 54.76M 20,643.18% | |
net cash provided by operating activities | -25.25M - | -21.70M 14.09% | -29.61M 36.48% | -42.07M 42.07% | -38.94M 7.45% | -32.58M 16.32% | -32.01M 1.74% | |
investments in property plant and equipment | -443K - | -2.28M 413.77% | -535K 76.49% | -842K 57.38% | -4.76M 465.08% | -5.00M 5.19% | -1.51M 69.89% | |
acquisitions net | 8.55M - | 2K 99.98% | 157.06M 7,853,050% | |||||
purchases of investments | -69.42M - | -79.91M 15.10% | -2K 100.00% | -168.16M 8,408,050% | -174.97M 4.05% | |||
sales maturities of investments | 71.36M - | 77.40M 8.47% | 11.10M 85.66% | 169.30M 1,425.23% | ||||
other investing activites | 6K - | -8.55M - | 2K 100.02% | -157.06M 7,853,250% | ||||
net cash used for investing activites | -443K - | -2.27M 412.42% | -69.96M 2,981.76% | -9.39M 86.57% | 72.64M 873.38% | -162.07M 323.10% | -7.18M 95.57% | |
debt repayment | -40M - | -49M - | ||||||
common stock issued | 338K - | 656K 94.08% | 111.94M 16,964.33% | 75.74M 32.34% | 6.95M 90.83% | 114.79M 1,552.58% | 3.89M 96.61% | |
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 46.82M - | 14.77M 68.46% | 1.81M 87.71% | 46.01M 2,434.99% | 32K 99.93% | 73.91M 230,871.88% | ||
net cash used provided by financing activities | 47.16M - | 15.42M 67.29% | 113.76M 637.53% | 81.75M 28.14% | 6.98M 91.46% | 139.70M 1,901.99% | 3.89M 97.22% | |
effect of forex changes on cash | 155K - | |||||||
net change in cash | 21.46M - | -8.54M 139.80% | 14.19M 266.15% | 30.29M 113.41% | 40.69M 34.35% | -54.95M 235.06% | -35.15M 36.04% | |
cash at beginning of period | 12.38M - | 33.84M 173.35% | 25.30M 25.24% | 39.49M 56.09% | 69.78M 76.69% | 110.46M 58.31% | 55.36M 49.89% | |
cash at end of period | 33.84M - | 25.30M 25.24% | 39.49M 56.09% | 69.78M 76.69% | 110.46M 58.31% | 55.51M 49.75% | 20.21M 63.59% | |
operating cash flow | -25.25M - | -21.70M 14.09% | -29.61M 36.48% | -42.07M 42.07% | -38.94M 7.45% | -32.58M 16.32% | -32.01M 1.74% | |
capital expenditure | -443K - | -2.28M 413.77% | -535K 76.49% | -842K 57.38% | -4.76M 465.08% | -5.00M 5.19% | -1.51M 69.89% | |
free cash flow | -25.70M - | -23.97M 6.71% | -30.14M 25.76% | -42.91M 42.35% | -43.69M 1.82% | -37.59M 13.98% | -33.52M 10.82% |
All numbers in USD (except ratios and percentages)